Surgical management of metastatic Hürthle cell carcinoma to the skull base, cortex, and spine: illustrative case

• DOI: 10.3171/case23263
• Publication Date: 2023-10-10T00:29:25Z
• Authors: N. U. Farrukh Hameed; Meagan M Hoppe; Ahmed Habib; Jeffrey Head; Regan Shanahan; Bradley A Gross; Sandra Narayanan; Georgios Zenonos; Pascal Zinn
• Keywords: Case Lesson; 3. Good health

BACKGROUND Hürthle cell carcinoma (HCC) is an unusual and aggressive variant of the follicular type of differentiated thyroid cancer (DTC), accounting for less than 3% of DTCs but posing the highest risk of metastasis. Brain metastases are uncommonly reported in the literature but pose a poor prognosis. The low rate of brain metastases from HCC coupled with ambiguous treatment protocols for the extracranial disease complicate successful disease management and definitive treatment strategy. The authors present the case of a patient with HCC metastasis to the skull base, cortex, and spine with recent tibial metastasis.

OBSERVATIONS Despite the presence of metastasis to the cortex, skull base, and spine, the patient responded very well to radiation therapy, sellar mass resection, and cervical spine decompression and fixation and has made a remarkable recovery.

LESSONS The authors’ multidisciplinary approach to the patient’s care, including a diverse team of specialists from oncology, neurosurgery, orthopedic surgery, radiology, endocrinology, and collaboration with clinical trial researchers, was fundamental to her successful outcome, demonstrating the utility of intersecting specialties in successful outcomes in neuro-oncological patient care.